{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:08:16Z","timestamp":1784822896906,"version":"3.55.0"},"reference-count":305,"publisher":"Elsevier","isbn-type":[{"value":"9780443418099","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2022RC1209"],"award-info":[{"award-number":["2022RC1209"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100985"],"award-info":[{"award-number":["32100985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270995"],"award-info":[{"award-number":["32270995"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303246"],"award-info":[{"award-number":["82303246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ50493"],"award-info":[{"award-number":["2025JJ50493"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ10034"],"award-info":[{"award-number":["2023JJ10034"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["202140456"],"award-info":[{"award-number":["202140456"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ41066"],"award-info":[{"award-number":["2023JJ41066"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.ircmb.2025.11.001","type":"book-chapter","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T21:35:13Z","timestamp":1764624913000},"page":"143-185","source":"Crossref","is-referenced-by-count":0,"title":["Neoantigen-based TCR-T therapy in solid tumors"],"prefix":"10.1016","author":[{"given":"Wenjie","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.ircmb.2025.11.001_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2020.12.005","article-title":"Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction","volume":"54","author":"Abelin","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.immuni.2019.08.012","article-title":"Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction","volume":"51","author":"Abelin","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/erv.10.24","article-title":"When gene therapy meets adoptive cell therapy: Better days ahead for cancer immunotherapy?","volume":"9","author":"Adamina","year":"2010","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/gt.2011.104","article-title":"Single-chain V\u03b1V\u03b2 T-cell receptors function without mispairing with endogenous TCR chains","volume":"19","author":"Aggen","year":"2012","journal-title":"Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib5","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900367","article-title":"Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection","volume":"2","author":"Albers","year":"2019","journal-title":"Life Science Alliance"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/bs.ircmb.2022.03.004","article-title":"Enabling CAR-T cells for solid tumors: Rage against the suppressive tumor microenvironment","volume":"370","author":"Anto\u00f1ana-Vildosola","year":"2022","journal-title":"International Review of Cell and Molecular Biology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092607","article-title":"The origin and immune recognition of tumor-specific antigens","volume":"12","author":"Apavaloaei","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI75876","article-title":"Survivin-specific T cell receptor targets tumor but not T cells","volume":"125","author":"Arber","year":"2015","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib9","doi-asserted-by":"crossref","first-page":"djv414","DOI":"10.1093\/jnci\/djv414","article-title":"Immunotherapy combined or sequenced with targeted therapy in the treatment of solid tumors: Current perspectives","volume":"108","author":"Atkins","year":"2016","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12967-023-04064-z","article-title":"Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading","volume":"21","author":"Azulay","year":"2023","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2016.04.005","article-title":"Mass spectrometry-based antigen discovery for cancer immunotherapy","volume":"41","author":"Bassani-Sternberg","year":"2016","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf3700","article-title":"TCR-engineered T cell therapy in solid tumors: State of the art and perspectives","volume":"9","author":"Baulu","year":"2023","journal-title":"Science Advances"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2009.09.004","article-title":"Kinetics of early T cell receptor signaling regulate the pathway of lytic granule delivery to the secretory domain","volume":"31","author":"Beal","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/14712598.2021.1857361","article-title":"Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy - what are we doing; where are we going?","volume":"21","author":"Bechman","year":"2021","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883989","article-title":"The importance of being presented: Target validation by immunopeptidomics for epitope-specific immunotherapies","volume":"13","author":"Becker","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib19","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1158\/1078-0432.CCR-07-4804","article-title":"Targeted therapies to improve tumor immunotherapy","volume":"14","author":"Begley","year":"2008","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nm.2128","article-title":"Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy","volume":"16","author":"Bendle","year":"2010","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061283","article-title":"Killing mechanisms of chimeric antigen receptor (CAR) T cells","volume":"20","author":"Benmebarek","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4303","article-title":"T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexes","author":"Bentzen","year":"2018","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib23","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.4049\/jimmunol.0902047","article-title":"Selected murine residues endow human TCR with enhanced tumor recognition","volume":"184","author":"Bialer","year":"2010","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41467-018-03301-0","article-title":"Sensitive and frequent identification of high avidity neo-epitope specific CD8 (+) T cells in immunotherapy-naive ovarian cancer","volume":"9","author":"Bobisse","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20061890","article-title":"In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor","volume":"204","author":"Boissonnas","year":"2007","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib27","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.2100700","article-title":"NeoScore integrates characteristics of the neoantigen:\u00a0MHC Class I interaction and expression to accurately prioritize immunogenic neoantigens","volume":"208","author":"Borden","year":"2022","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1532759","article-title":"Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: Strategy for selection of an optimal candidate","volume":"8","author":"Border","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.omto.2023.02.005","article-title":"Seneca valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression","volume":"28","author":"Bryant","year":"2023","journal-title":"Molecular Therapy Oncolytics"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib30","article-title":"Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification","author":"Bulik-Sullivan","year":"2018","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3251","article-title":"Tumour immunogenicity: Editorial selection demystified","volume":"12","author":"Burgess","year":"2012","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib32","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/testis (CT) antigens: Potential targets for immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Science"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41467-019-08304-z","article-title":"Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients","volume":"10","author":"Cafri","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib34","article-title":"Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy","volume":"12","author":"Cai","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib35","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022017378","article-title":"Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci","author":"Calabria","year":"2023","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Computational Biology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002412","article-title":"Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire","volume":"8","author":"Calis","year":"2012","journal-title":"PLoS Computational Biology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00251-014-0815-0","article-title":"Role of peptide processing predictions in T cell epitope identification: Contribution of different prediction programs","volume":"67","author":"Calis","year":"2015","journal-title":"Immunogenetics"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071720","article-title":"The quest for the best: How TCR affinity, avidity, and functional avidity affect TCR-engineered T-cell antitumor responses","volume":"9","author":"Campillo-Davo","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib40","article-title":"FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer","author":"Canel","year":"2023","journal-title":"Gut"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2478\/jtim-2023-0081","article-title":"A cycloruthenated complex, ruthenium (II) Z (RuZ) overcomes in vitro and in vivo multidrug resistance in cancer cells: A pivotal breakthrough","volume":"11","author":"Cao","year":"2023","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1074-7613(03)00351-0","article-title":"Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2","volume":"20","author":"Carpino","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12967-021-02757-x","article-title":"Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy","volume":"19","author":"Cavalluzzo","year":"2021","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2008.06.014","article-title":"The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality","volume":"29","author":"Cemerski","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/imr.12772","article-title":"T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance","volume":"290","author":"Chandran","year":"2019","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib46","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41591-022-01786-3","article-title":"Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA","volume":"28","author":"Chandran","year":"2022","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/14712598.2016.1176138","article-title":"Opportunities and challenges for TCR mimic antibodies in cancer therapy","volume":"16","author":"Chang","year":"2016","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-0716-2014-4_7","article-title":"Transcriptomic-assisted immune and neoantigen profiling in premalignancy","volume":"2435","author":"Chang","year":"2022","journal-title":"Methods in Molecular Biology (Clifton, N. J.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib49","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1002\/cam4.2223","article-title":"Comprehensive characterization of cancer-testis genes in testicular germ cell tumor","volume":"8","author":"Chang","year":"2019","journal-title":"Cancer Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib50","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1200\/JCO.2015.65.5142","article-title":"T-cell therapy using interleukin-21-primed cytotoxic T-cell lymphocytes combined with cytotoxic T-cell lymphocyte antigen-4 blockade results in long-term cell persistence and durable tumor regression","volume":"34","author":"Chapuis","year":"2016","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib51","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(19)31774-X","article-title":"Antibody-drug conjugates for cancer","volume":"394","author":"Chau","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib53","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1073\/pnas.0502583102","article-title":"Identification of cancer\/testis-antigen genes by massively parallel signature sequencing","volume":"102","author":"Chen","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib54","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12967-024-05134-6","article-title":"CD8(+) T cell-based cancer immunotherapy","volume":"22","author":"Chen","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.1001775","article-title":"A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer","volume":"186","author":"Chinnasamy","year":"2011","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib56","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1158\/0008-5472.CAN-11-0103","article-title":"IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression","volume":"71","author":"Chmielewski","year":"2011","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4049\/jimmunol.163.1.507","article-title":"Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity","volume":"163","author":"Clay","year":"1999","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12967-021-02829-y","article-title":"Is immunotherapy in the future of therapeutic management of sarcomas?","volume":"19","author":"Clemente","year":"2021","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib59","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.4049\/jimmunol.175.9.5799","article-title":"Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR","volume":"175","author":"Cohen","year":"2005","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib60","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1158\/0008-5472.CAN-06-1450","article-title":"Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR\/CD3 stability","volume":"66","author":"Cohen","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib61","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.4049\/jimmunol.178.9.5727","article-title":"Human TCR-binding affinity is governed by MHC class restriction","volume":"178","author":"Cole","year":"2007","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib62","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1073\/pnas.92.17.7976","article-title":"A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma","volume":"92","author":"Coulie","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib63","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/annonc\/mdz398","article-title":"Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis","volume":"30","author":"Dafni","year":"2019","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology \/ ESMO"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib64","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12967-023-04292-3","article-title":"Harnessing the potential of CAR-T cell therapy: Progress, challenges, and future directions in hematological and solid tumor treatments","volume":"21","author":"Dagar","year":"2023","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib65","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/biot.200800144","article-title":"Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: Implications for immunotherapy in South African populations","volume":"3","author":"Dakshinamurthy","year":"2008","journal-title":"Biotechnology Journal"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib66","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-10-1280","article-title":"Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials","volume":"16","author":"Davis","year":"2010","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib67","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.immunol.16.1.523","article-title":"Ligand recognition by alpha beta T cell receptors","volume":"16","author":"Davis","year":"1998","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib68","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.annonc.2020.05.008","article-title":"Neoantigen prediction and computational perspectives towards clinical benefit: Recommendations from the ESMO precision medicine working group","volume":"31","author":"De Mattos-Arruda","year":"2020","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib69","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/320232a0","article-title":"Transfer of specificity by murine alpha and beta T-cell receptor genes","volume":"320","author":"Dembi\u0107","year":"1986","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib70","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-18-0573","article-title":"T-cell responses to TP53 \u201cHotspot\u201d mutations and unique neoantigens expressed by human ovarian cancers","volume":"24","author":"Deniger","year":"2018","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib71","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-019-0051-2","article-title":"Off-the-shelf\u2019 allogeneic CAR T cells: Development and challenges","volume":"19","author":"Depil","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib72","first-page":"288","article-title":"RN486, a Bruton\u2019s tyrosine kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells","volume":"12","author":"Dong","year":"2024","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2478\/jtim-2023-0091","article-title":"Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism","volume":"11","author":"Dou","year":"2023","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12033-007-0021-5","article-title":"Adenoviral vectors for gene therapy","volume":"36","author":"Douglas","year":"2007","journal-title":"Molecular Biotechnology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib75","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","article-title":"Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens","volume":"26","author":"Dudley","year":"2008","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib76","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s40425-019-0773-z","article-title":"Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes","volume":"7","author":"Duong","year":"2019","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib77","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/imr.12008","article-title":"Non-catalytic tyrosine-phosphorylated receptors","volume":"250","author":"Dushek","year":"2012","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-cellbio-100814-125330","article-title":"Signaling and polarized communication across the T cell immunological synapse","volume":"32","author":"Dustin","year":"2016","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib79","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12967-022-03624-z","article-title":"Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination","volume":"20","author":"Ellingsen","year":"2022","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.28.2.113","article-title":"Immunotherapy for cancer: The use of lymphokine activated killer (LAK) cells","volume":"28","author":"Fagan","year":"1987","journal-title":"Gut"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib81","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/imt.10.73","article-title":"Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease","volume":"2","author":"Ferrara","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658372","article-title":"ARTEMIS: A novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery","volume":"12","author":"Finton","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib83","first-page":"1","article-title":"Non-viral precision T\u2009cell receptor replacement for personalized cell therapy","author":"Foy","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib84","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/imm.12936","article-title":"Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry","volume":"154","author":"Freudenmann","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092095","article-title":"Breaking bottlenecks for the TCR therapy of cancer","volume":"9","author":"Gaissmaier","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib87","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.0105-2896.2006.00348.x","article-title":"Central tolerance: Good but imperfect","volume":"209","author":"Gallegos","year":"2006","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib88","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting metastatic cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib89","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fimmu.2019.01392","article-title":"Determinants for neoantigen identification","volume":"10","author":"Garcia-Garijo","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib90","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/mt.2011.167","article-title":"Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma","volume":"19","author":"Gerdemann","year":"2011","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.addr.2019.04.002","article-title":"Synthetic T cell receptor-based lymphocytes for cancer therapy","volume":"141","author":"Getts","year":"2019","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib92","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2217\/imt.13.165","article-title":"Cancer-testis genes as candidates for immunotherapy in breast cancer","volume":"6","author":"Ghafouri-Fard","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib93","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00262-016-1897-3","article-title":"Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes","volume":"65","author":"Gloger","year":"2016","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib94","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1186\/s12967-024-05703-9","article-title":"TCR-T cell therapy: Current development approaches, preclinical evaluation, and perspectives on regulatory challenges","volume":"22","author":"Golikova","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428190400002202","article-title":"Adoptive immunotherapy for EBV-associated malignancies","volume":"46","author":"Gottschalk","year":"2005","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib96","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.4049\/jimmunol.1302074","article-title":"TCRs genetically linked to CD28 and CD3\u03b5 do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity","volume":"193","author":"Govers","year":"2014","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2019.09.006","article-title":"Combination immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors","volume":"36","author":"Grosser","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195868","article-title":"Soluble T-cell receptor design influences functional yield in an E. coli chaperone-assisted expression system","volume":"13","author":"Gunnarsen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib99","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","article-title":"Melanoma cell expression of Fas(Apo-1\/CD95) ligand: Implications for tumor immune escape","volume":"274","author":"Hahne","year":"1996","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.aba9844","article-title":"Knocking out barriers to engineered cell activity","volume":"367","author":"Hamilton","year":"2020","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib101","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/2326-6066.CIR-22-0761","article-title":"Low TCR binding strength results in increased progenitor-like CD8+ tumor-infiltrating lymphocytes","volume":"11","author":"Hay","year":"2023","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib102","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-22-0761","article-title":"Low TCR binding strength results in increased progenitor-like CD8+ tumor-infiltrating lymphocytes","author":"Hay","year":"2023","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib103","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41422-022-00627-9","article-title":"Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response","volume":"32","author":"He","year":"2022","journal-title":"Cell Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib104","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fimmu.2015.00582","article-title":"Identifying individual T cell receptors of optimal avidity for tumor antigens","volume":"6","author":"Hebeisen","year":"2015","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib105","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1172\/JCI65325","article-title":"SHP-1 phosphatase activity counteracts increased T cell receptor affinity","volume":"123","author":"Hebeisen","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib107","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ymthe.2018.12.010","article-title":"Improving T cell receptor on-target specificity via structure-guided design","volume":"27","author":"Hellman","year":"2019","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib108","doi-asserted-by":"crossref","first-page":"20422","DOI":"10.1073\/pnas.0810777105","article-title":"Genome-wide analysis of cancer\/testis gene expression","volume":"105","author":"Hofmann","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib109","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1073\/pnas.080078297","article-title":"In vitro evolution of a T cell receptor with high affinity for peptide\/MHC","volume":"97","author":"Holler","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib110","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ymthe.2018.01.012","article-title":"Efficient non-viral gene delivery into human hematopoietic stem cells by minicircle sleeping beauty transposon vectors","volume":"26","author":"Holstein","year":"2018","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib111","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","article-title":"Engineering CAR-T cells for next-generation cancer therapy","volume":"38","author":"Hong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib112","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib113","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12967-025-06093-2","article-title":"Application of adoptive cell therapy in malignant melanoma","volume":"23","author":"Hu","year":"2025","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib114","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1158\/2326-6066.CIR-19-0401","article-title":"pVACtools: A computational toolkit to identify and visualize cancer neoantigens","volume":"8","author":"Hundal","year":"2020","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addr.2018.09.002","article-title":"Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy","volume":"141","author":"Hutmacher","year":"2019","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib116","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","article-title":"Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development","volume":"52","author":"Hwang","year":"2020","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/srep17875","article-title":"Systematic comparison of variant calling pipelines using gold standard personal exome variants","volume":"5","author":"Hwang","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104277","article-title":"Reactive myelopoiesis and the onset of myeloid-mediated immune suppression: Implications for adoptive cell therapy","volume":"361","author":"Innamarato","year":"2021","journal-title":"Cellular Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib119","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ymthe.2020.06.025","article-title":"Reactive myelopoiesis triggered by lymphodepleting chemotherapy limits the efficacy of adoptive T cell therapy","volume":"28","author":"Innamarato","year":"2020","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib120","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41467-020-20166-4","article-title":"Thermostability profiling of MHC-bound peptides: A new dimension in immunopeptidomics and aid for immunotherapy design","volume":"11","author":"Jappe","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib121","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2010.02.008","article-title":"The synapse and cytolytic machinery of cytotoxic T cells","volume":"22","author":"Jenkins","year":"2010","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib122","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2009.08.024","article-title":"The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse","volume":"31","author":"Jenkins","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib123","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-021-00868-x","article-title":"Emerging new therapeutic antibody derivatives for cancer treatment","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib124","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib125","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.4049\/jimmunol.177.9.6548","article-title":"Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes","volume":"177","author":"Johnson","year":"2006","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/imm.12160","article-title":"NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery","volume":"141","author":"J\u00f8rgensen","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib127","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4939-8868-6_9","article-title":"Computational methods for identification of T cell neoepitopes in tumors","volume":"1878","author":"Jurtz","year":"2019","journal-title":"Methods in Molecular Biology (Clifton, N. J.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","article-title":"Comprehensive analysis of alternative splicing across tumors from 8,705 patients","volume":"34","author":"Kahles","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib130","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/2159-8290.CD-17-1418","article-title":"Combined analysis of antigen presentation and t-cell recognition reveals restricted immune responses in melanoma","volume":"8","author":"Kalaora","year":"2018","journal-title":"Cancer Discovery"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41568-022-00442-9","article-title":"Mechanisms of immune activation and regulation: Lessons from melanoma","volume":"22","author":"Kalaora","year":"2022","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib132","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bj.2022.04.002","article-title":"The ins and outs of T cell signaling","volume":"45","author":"Kanellopoulos","year":"2022","journal-title":"Biomedical Journal"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib133","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cas.13131","article-title":"Prediction and prioritization of neoantigens: Integration of RNA sequencing data with whole-exome sequencing","volume":"108","author":"Karasaki","year":"2017","journal-title":"Cancer Science"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib134","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2478\/jtim-2024-0025","article-title":"Actin-related protein 2\/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT\/PI3K\/mTOR signaling pathway","volume":"12","author":"Ke","year":"2024","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib136","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2174\/0929867324666170817152554","article-title":"Antibody fragments as potential biopharmaceuticals for cancer therapy: Success and limitations","volume":"26","author":"Kholodenko","year":"2019","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib137","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1158\/2326-6066.CIR-22-0040","article-title":"Adoptive cellular therapy with autologous tumor-infiltrating lymphocytes and t-cell receptor-engineered T cells targeting common p53 neoantigens in human solid tumors","volume":"10","author":"Kim","year":"2022","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib138","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.2010.00979.x","article-title":"Therapeutic cancer vaccines: Are we there yet?","volume":"239","author":"Klebanoff","year":"2011","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib139","doi-asserted-by":"crossref","first-page":"21199","DOI":"10.18632\/oncotarget.8385","article-title":"An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells","volume":"7","author":"Knies","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-065X.1985.tb01130.x","article-title":"Genetic complexity and expression of human class II histocompatibility antigens","volume":"85","author":"Korman","year":"1985","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030535","article-title":"Mass spectrometry-based identification of MHC-associated peptides","volume":"12","author":"Kote","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib142","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-022-03442-3","article-title":"Exhaustion of CAR T cells: Potential causes and solutions","volume":"20","author":"Kouro","year":"2022","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib143","first-page":"E6649","article-title":"A conserved \u03b1\u03b2 transmembrane interface forms the core of a compact T-cell receptor-CD3 structure within the membrane","volume":"113","author":"Krshnan","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib144","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.immuni.2006.01.006","article-title":"Deconstructing the form and function of the TCR\/CD3 complex","volume":"24","author":"Kuhns","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib145","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.4049\/jimmunol.1502024","article-title":"MAGE-C2-specific TCRs combined with epigenetic drug-enhanced antigenicity yield robust and tumor-selective T cell responses","volume":"197","author":"Kunert","year":"2016","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib146","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1158\/1078-0432.CCR-17-1012","article-title":"T-cell receptors for clinical therapy: In vitro assessment of toxicity risk","volume":"23","author":"Kunert","year":"2017","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib147","article-title":"Clathrin mediates both internalization and vesicular release of triggered T cell receptor at the immunological synapse","volume":"120","author":"Kvalvaag","year":"2023","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib148","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(01)00170-4","article-title":"How much TCR does a T cell need?","volume":"15","author":"Labrecque","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib149","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1158\/0008-5472.CAN-21-0302","article-title":"Moving toward the ideal autologous adoptive T-cell therapy for cancer","volume":"81","author":"Ladle","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib150","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.135.6.4273","article-title":"Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma","volume":"135","author":"Lafreniere","year":"1985","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib151","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib152","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","article-title":"CAR T cell killing requires the IFN\u03b3R pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib153","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5516","article-title":"Noncoding regions are the main source of targetable tumor-specific antigens","volume":"10","author":"Laumont","year":"2018","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib154","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/d41586-022-03676-7","article-title":"CRISPR cancer trial success paves the way for personalized treatments","volume":"611","author":"Ledford","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib155","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1086507","article-title":"The immunological synapse balances T cell receptor signaling and degradation","volume":"302","author":"Lee","year":"2003","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib156","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1038\/s41598-021-85352-w","article-title":"Non-specific interactions of antibody-oligonucleotide conjugates with living cells","volume":"11","author":"Lehot","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib157","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib158","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1073\/pnas.0500090102","article-title":"The response of autologous T cells to a human melanoma is dominated by mutated neoantigens","volume":"102","author":"Lennerz","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib159","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccell.2022.04.013","article-title":"Fast track to personalized TCR T cell therapies","volume":"40","author":"Levy","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41592-018-0305-7","article-title":"T cell antigen discovery via trogocytosis","volume":"16","author":"Li","year":"2019","journal-title":"Nature Methods"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib161","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12967-024-05206-7","article-title":"The potential and promise for clinical application of adoptive T cell therapy in cancer","volume":"22","author":"Li","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib162","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nm.2764","article-title":"Monoclonal TCR-redirected tumor cell killing","volume":"18","author":"Liddy","year":"2012","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib163","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib164","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib165","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1186\/s12967-024-05903-3","article-title":"CAR-armored-cell therapy in solid tumor treatment","volume":"22","author":"Liu","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib166","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2478\/jtim-2023-0105","article-title":"A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma","volume":"11","author":"Liu","year":"2023","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib167","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/jtim-2023-0089","article-title":"A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients","volume":"11","author":"Liu","year":"2023","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib168","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1158\/2326-6066.CIR-18-0686","article-title":"Immunologic recognition of a shared p53 mutated neoantigen in a patient with metastatic colorectal cancer","volume":"7","author":"Lo","year":"2019","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib169","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.165.6.3080","article-title":"Critical relationship between TCR signaling potential and TCR affinity during thymocyte selection","volume":"165","author":"Love","year":"2000","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.690565","article-title":"Neoantigen specific T cells derived from T cell-derived induced pluripotent stem cells for the treatment of hepatocellular carcinoma: Potential and challenges","volume":"12","author":"Lu","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib171","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymthe.2017.10.018","article-title":"An efficient single-cell RNA-Seq approach to identify neoantigen-specific T cell receptors","volume":"26","author":"Lu","year":"2018","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib172","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1158\/1078-0432.CCR-14-0433","article-title":"Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions","volume":"20","author":"Lu","year":"2014","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib173","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1096\/fj.07-9331hyp","article-title":"The receptor deformation model of TCR triggering","volume":"22","author":"Ma","year":"2008","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib174","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1158\/1078-0432.CCR-19-1874","article-title":"Antigen experienced T cells from peripheral blood recognize p53 neoantigens","volume":"26","author":"Malekzadeh","year":"2020","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib175","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3389\/fimmu.2020.01689","article-title":"TCR redirected T cells for cancer treatment: Achievements, hurdles, and goals","volume":"11","author":"Manfredi","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib176","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymthe.2017.10.012","article-title":"Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients","volume":"26","author":"Marcucci","year":"2018","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib177","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0021-9258(17)49904-2","article-title":"The structural basis of T-cell receptor (TCR) activation: An enduring enigma","volume":"295","author":"Mariuzza","year":"2020","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib178","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1182\/blood-2009-09-241398","article-title":"IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice","volume":"115","author":"Markley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib179","doi-asserted-by":"crossref","first-page":"ra43","DOI":"10.1126\/scisignal.2000402","article-title":"Cooperativity between T cell receptor complexes revealed by conformational mutants of CD3epsilon","volume":"2","author":"Mart\u00ednez-Mart\u00edn","year":"2009","journal-title":"Science Signaling"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mto.2016.23","article-title":"An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity","volume":"3","author":"Maus","year":"2016","journal-title":"Molecular Therapy Oncolytics"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib182","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s12072-021-10250-2","article-title":"Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial","volume":"15","author":"Meng","year":"2021","journal-title":"Hepatology International"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib183","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ymthe.2020.03.009","article-title":"CRISPR-edited immune effectors: The end of the beginning","volume":"28","author":"Mo","year":"2020","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib184","article-title":"The kinase occupancy of T cell coreceptors reconsidered","volume":"119","author":"M\u00f8rch","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib185","first-page":"133","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Morgan","year":"2013","journal-title":"Journal of immunotherapy (Hagerstown, Md.: 1997)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib186","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib187","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.4049\/jimmunol.171.6.3287","article-title":"High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens","volume":"171","author":"Morgan","year":"2003","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib188","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib189","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2016.01.012","article-title":"Engineering customized cell sensing and response behaviors using synthetic notch receptors","volume":"164","author":"Morsut","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib190","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.6332379","article-title":"Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2","volume":"225","author":"Mul\u00e9","year":"1984","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment","volume":"17","author":"Nakamura","year":"2020","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib192","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2567.2010.03268.x","article-title":"MHC class II epitope predictive algorithms","volume":"130","author":"Nielsen","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib193","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00251-005-0781-7","article-title":"The role of the proteasome in generating cytotoxic T-cell epitopes: Insights obtained from improved predictions of proteasomal cleavage","volume":"57","author":"Nielsen","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib194","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.molimm.2003.11.005","article-title":"A powerful combination: The use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes","volume":"40","author":"Nino-Vasquez","year":"2004","journal-title":"Molecular Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib195","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00002371-199809000-00003","article-title":"T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines","volume":"21","author":"Nishimura","year":"1998","journal-title":"Journal of immunotherapy (Hagerstown, Md.: 1997)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.750478","article-title":"Double strike approach for tumor attack: Engineering T cells using a CD40L:CD28 chimeric co-stimulatory switch protein for enhanced tumor targeting in adoptive cell therapy","volume":"12","author":"Olgu\u00edn-Contreras","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib197","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8(+) T cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib198","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.4049\/jimmunol.1301769","article-title":"Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity\/avidity thresholds","volume":"193","author":"Oren","year":"2014","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib199","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41587-021-01021-3","article-title":"Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer","volume":"40","author":"Ouspenskaia","year":"2022","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib201","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","article-title":"CAR race to cancer immunotherapy: From CAR T, CAR NK to CAR macrophage therapy","volume":"41","author":"Pan","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib202","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1158\/1078-0432.CCR-16-2680","article-title":"Isolation of T-cell receptors specifically reactive with mutated tumor-associated antigens from tumor-infiltrating lymphocytes based on CD137 expression","volume":"23","author":"Parkhurst","year":"2017","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib203","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/mt.2010.272","article-title":"T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis","volume":"19","author":"Parkhurst","year":"2011","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib204","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-18-1494","article-title":"Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers","volume":"9","author":"Parkhurst","year":"2019","journal-title":"Cancer Discovery"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib205","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.944927","article-title":"Editorial: First regulatory approval for adoptive cell therapy with autologous tumor-infiltrating lymphocytes (TILs) - Lifileucel (Amtagvi)","volume":"30","author":"Parums","year":"2024","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib206","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: An emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Molecular Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib207","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib208","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12967-024-06052-3","article-title":"From ex vivo to in vivo chimeric antigen T cells manufacturing: New horizons for CAR T-cell based therapy","volume":"23","author":"Pinto","year":"2025","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib209","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib210","article-title":"Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation","author":"Pyke","year":"2023","journal-title":"Molecular & Cellular Proteomics: MCP"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib211","first-page":"599","article-title":"[A method of screening highly common neoantigens with immunogenicity in colorectal cancer based on public somatic mutation library]","volume":"42","author":"Qin","year":"2020","journal-title":"Yi chuan = Hereditas"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib212","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41587-019-0291-z","article-title":"A highly soluble sleeping beauty transposase improves control of gene insertion","volume":"37","author":"Querques","year":"2019","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib213","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12967-022-03512-6","article-title":"Molecular mimicry between tumor associated antigens and microbiota-derived epitopes","volume":"20","author":"Ragone","year":"2022","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib214","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: Harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib216","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.4049\/jimmunol.180.9.6116","article-title":"Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions","volume":"180","author":"Robbins","year":"2008","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib217","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib218","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib219","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3389\/fimmu.2020.01109","article-title":"CAR-T cells hit the tumor microenvironment: Strategies to overcome tumor escape","volume":"11","author":"Rodriguez-Garcia","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib221","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM199008303230904","article-title":"Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction","volume":"323","author":"Rosenberg","year":"1990","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib222","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","article-title":"Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer","volume":"313","author":"Rosenberg","year":"1985","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib223","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7326\/0003-4819-108-6-853","article-title":"NIH conference. New approaches to the immunotherapy of cancer using interleukin-2","volume":"108","author":"Rosenberg","year":"1988","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib224","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib225","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: Moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib226","first-page":"595","article-title":"Lymphokine-activated killer cells: A new approach to immunotherapy of cancer","volume":"75","author":"Rosenberg","year":"1985","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib227","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib228","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","article-title":"Precision tumor recognition by T cells with combinatorial antigen-sensing circuits","volume":"164","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib229","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","article-title":"Precision tumor recognition by T cells with combinatorial antigen-sensing circuits","volume":"164","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib230","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.immunol.23.021704.115658","article-title":"How TCRs bind MHCs, peptides, and coreceptors","volume":"24","author":"Rudolph","year":"2006","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib231","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081998","article-title":"T-Cells expressing a highly potent PRAME-specific T-Cell receptor in combination with a chimeric PD1-41BB co-stimulatory receptor show a favorable preclinical safety profile and strong anti-tumor reactivity","volume":"14","author":"Sailer","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib232","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/329256a0","article-title":"Predictable acquisition of a new MHC recognition specificity following expression of a transfected T-cell receptor beta-chain gene","volume":"329","author":"Saito","year":"1987","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib233","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abe2606","article-title":"Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function","volume":"14","author":"Salter","year":"2021","journal-title":"Science Signaling"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib234","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","article-title":"A large peptidome dataset improves HLA class I epitope prediction across most of the human population","volume":"38","author":"Sarkizova","year":"2020","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.780399","article-title":"Implementing logic gates for safer immunotherapy of cancer","volume":"12","author":"Savanur","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib236","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4049\/jimmunol.1601661","article-title":"The allostery model of TCR regulation","volume":"198","author":"Schamel","year":"2017","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib237","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","article-title":"Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers","volume":"25","author":"Scheper","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib238","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib239","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3279","article-title":"Why must T cells be cross-reactive?","volume":"12","author":"Sewell","year":"2012","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: Progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib241","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/mab.2021.0003","article-title":"Bringing together the power of T cell receptor mimic and bispecific antibodies for cancer immunotherapy: Still a long way to go","volume":"40","author":"Shivarov","year":"2021","journal-title":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib242","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1158\/2159-8290.CD-17-0538","article-title":"Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells","volume":"7","author":"Shum","year":"2017","journal-title":"Cancer Discovery"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib243","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nbt.4239","article-title":"Intron retention is a source of neoepitopes in cancer","volume":"36","author":"Smart","year":"2018","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib244","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41568-019-0162-4","article-title":"Alternative tumour-specific antigens","volume":"19","author":"Smith","year":"2019","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib245","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2326-6066.CIR-19-0690","article-title":"Inhibition of SHP-1 expands the repertoire of antitumor T cells available to respond to immune checkpoint blockade","volume":"8","author":"Snook","year":"2020","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib246","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00262-019-02401-0","article-title":"Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy","volume":"68","author":"Spear","year":"2019","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib247","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4049\/jimmunol.149.1.65","article-title":"Signals delivered via MHC class II molecules synergize with signals delivered via TCR\/CD3 to cause proliferation and cytokine gene expression in T cells","volume":"149","author":"Spertini","year":"1992","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib248","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib249","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ni1001-962","article-title":"Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer","volume":"2","author":"Stanislawski","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.cellbio.23.090506.123521","article-title":"Secretory mechanisms in cell-mediated cytotoxicity","volume":"23","author":"Stinchcombe","year":"2007","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib251","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(01)00234-5","article-title":"The immunological synapse of CTL contains a secretory domain and membrane bridges","volume":"15","author":"Stinchcombe","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib252","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature05071","article-title":"Centrosome polarization delivers secretory granules to the immunological synapse","volume":"443","author":"Stinchcombe","year":"2006","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib253","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2567.2008.03015.x","article-title":"T-cell receptor binding affinities and kinetics: Impact on T-cell activity and specificity","volume":"126","author":"Stone","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib254","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/ijc.34382","article-title":"Immunotherapies targeting neoantigens are effective in PD-1 blockade-resistant tumors","volume":"152","author":"Sun","year":"2023","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib255","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1515\/jtim-2024-0019","article-title":"Histological transformation in lung adenocarcinoma: Insights of mechanisms and therapeutic windows","volume":"12","author":"Tan","year":"2024","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib256","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/acscentsci.2c01437","article-title":"Modular chemical construction of IgG-like mono- and bispecific synthetic antibodies (SynAbs)","volume":"9","author":"Thoreau","year":"2023","journal-title":"ACS Central Science"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib257","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2478\/jtim-2023-0002","article-title":"A pan-cancer analysis of the oncogenic role of Golgi transport 1B in human tumors","volume":"11","author":"Tian","year":"2023","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib258","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/hum.2017.128","article-title":"Transposons: Moving forward from preclinical studies to clinical trials","volume":"28","author":"Tipanee","year":"2017","journal-title":"Human Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib259","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-Cell transfer therapy targeting mutant KRAS in cancer","volume":"375","author":"Tran","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib260","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3389\/fimmu.2017.01001","article-title":"Therapeutic antibodies against intracellular tumor antigens","volume":"8","author":"Trenevska","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib261","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/cncr.28547","article-title":"Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation","volume":"120","author":"Tseng","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib262","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.reth.2021.02.006","article-title":"Immune evasion by cancer stem cells","volume":"17","author":"Tsuchiya","year":"2021","journal-title":"Regenerative Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib263","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/375148a0","article-title":"Serial triggering of many T-cell receptors by a few peptide-MHC complexes","volume":"375","author":"Valitutti","year":"1995","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib264","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-065X.2002.18806.x","article-title":"Tumor-specific shared antigenic peptides recognized by human T cells","volume":"188","author":"Van Der Bruggen","year":"2002","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib266","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1200\/JCO.2012.47.7521","article-title":"Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma","volume":"31","author":"van Rooij","year":"2013","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib267","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.immuni.2006.04.010","article-title":"T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster","volume":"25","author":"Varma","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib268","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"2016 update of the PRIDE database and its related tools","volume":"44","author":"Vizca\u00edno","year":"2016","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib269","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib270","first-page":"225","article-title":"A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma","volume":"12","author":"Wang","year":"2024","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib271","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41467-020-15229-5","article-title":"An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses","volume":"11","author":"Wang","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib272","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.trecan.2021.10.007","article-title":"Exploiting T cell signaling to optimize engineered T cell therapies","volume":"8","author":"Wang","year":"2022","journal-title":"Trends in Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib273","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1515\/jtim-2023-0133","article-title":"Development and validation of web-based risk score predicting prognostic nomograms for elderly patients with primary colorectal lymphoma: A population-based study","volume":"12","author":"Wang","year":"2024","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib274","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1479-5876-2-41","article-title":"Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells","volume":"2","author":"Wang","year":"2004","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib275","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/bib\/bbaa026","article-title":"Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer","volume":"22","author":"Wang","year":"2021","journal-title":"Briefings in Bioinformatics"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib276","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s12967-023-04514-8","article-title":"B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of V\u03b39V\u03b42 T cells in glioblastoma","volume":"21","author":"Wang","year":"2023","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib277","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3389\/fimmu.2018.02486","article-title":"Expanding the therapeutic window for CAR T cell therapy in solid tumors: The knowns and unknowns of CAR T cell biology","volume":"9","author":"Watanabe","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib278","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction","volume":"183","author":"Wells","year":"2020","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib279","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib280","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1038\/s41467-021-23713-9","article-title":"Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics","volume":"12","author":"Wilhelm","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib281","doi-asserted-by":"crossref","first-page":"27491","DOI":"10.1074\/jbc.M500555200","article-title":"Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface","volume":"280","author":"Wooldridge","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib282","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/s41467-020-16755-y","article-title":"Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen","volume":"11","author":"Wu","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101684","article-title":"T cell receptors employ diverse strategies to target a p53 cancer neoantigen","volume":"298","author":"Wu","year":"2022","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib284","doi-asserted-by":"crossref","first-page":"a005140","DOI":"10.1101\/cshperspect.a005140","article-title":"Structural biology of the T-cell receptor: Insights into receptor assembly, ligand recognition, and initiation of signaling","volume":"2","author":"Wucherpfennig","year":"2010","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ni741","article-title":"Costimulation and endogenous MHC ligands contribute to T cell recognition","volume":"3","author":"W\u00fclfing","year":"2002","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib286","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2478\/jtim-2023-0122","article-title":"Circular RNA: A promising new star of vaccine","volume":"11","author":"Xie","year":"2023","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib287","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: Promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.cels.2023.03.001","article-title":"Entropic analysis of antigen-specific CDR3 domains identifies essential binding motifs shared by CDR3s with different antigen specificities","author":"Xu","year":"2023","journal-title":"Cell Systems"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib289","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1186\/s12967-024-05825-0","article-title":"The intratumoral landscape of T cell receptor repertoire in esophageal squamous cell carcinoma","volume":"22","author":"Yang","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib290","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jtho.2021.01.1624","article-title":"The current lung cancer neoantigen landscape and implications for therapy","volume":"16","author":"Ye","year":"2021","journal-title":"Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib291","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.2009.00779.x","article-title":"Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters","volume":"229","author":"Yokosuka","year":"2009","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib292","first-page":"365","article-title":"Use of fluorogenic histocompatibility leukocyte antigen-A*0201\/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens","volume":"60","author":"Youde","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib293","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1891814","article-title":"Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer","volume":"18","author":"Yu","year":"2022","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib294","first-page":"317","article-title":"Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer","volume":"12","author":"Zhang","year":"2024","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib295","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2478\/jtim-2023-0123","article-title":"Crosstalk between gut microbiota and gut resident macrophages in inflammatory bowel disease","volume":"11","author":"Zhang","year":"2023","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib296","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2478\/jtim-2023-0136","article-title":"Impacts of cryopreservation on phenotype and functionality of mononuclear cells in peripheral blood and ascites","volume":"12","author":"Zhang","year":"2024","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib297","article-title":"Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy","volume":"120","author":"Zhang","year":"2019","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib298","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib299","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/2326-6066.CIR-19-0541","article-title":"Proteogenomics uncovers a vast repertoire of shared tumor-specific antigens in ovarian cancer","volume":"8","author":"Zhao","year":"2020","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib300","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s12967-022-03713-z","article-title":"Scoring model based on the signature of non-m6A-related neoantigen-coding lncRNAs assists in immune microenvironment analysis and TCR-neoantigen pair selection in gliomas","volume":"20","author":"Zhao","year":"2022","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib301","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.4049\/jimmunol.179.9.5845","article-title":"High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines","volume":"179","author":"Zhao","year":"2007","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib302","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1073\/pnas.1221609110","article-title":"T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy","volume":"110","author":"Zhong","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib303","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.immuni.2010.03.006","article-title":"CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development","volume":"32","author":"Zikherman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib304","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/248701a0","article-title":"Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system","volume":"248","author":"Zinkernagel","year":"1974","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.11.001_bib305","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1515\/jtim-2024-0038","article-title":"Intratumoral microbiota in orchestrating cancer immunotherapy response","volume":"12","author":"Zou","year":"2024","journal-title":"Journal of Translational Internal Medicine"}],"container-title":["International Review of Cell and Molecular Biology","Advances in biomedical engineering - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644825001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644825001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:24:07Z","timestamp":1784820247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644825001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443418099"],"references-count":305,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2025.11.001","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}